Different Affinities of Inhibitors to the Outwardly and Inwardly Directed Substrate Binding Site of Organic Cation Transporter 2
- 1 November 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 64 (5) , 1037-1047
- https://doi.org/10.1124/mol.64.5.1037
Abstract
The rat organic cation transporter 2 (rOCT2) was expressed in Xenopus laevis oocytes and cation-induced outward and inward currents were measured in whole cells and giant patches using voltage clamp techniques. Tetrabutylammonium (TBuA) and corticosterone were identified as nontransported inhibitors that bind to the substrate binding site of rOCT2. They inhibited cation-induced currents from both membrane sides. Increased substrate concentrations could partially overcome the inhibition. At 0 mV, the affinity of TBuA from the extracellular side compared with the intracellular side of the membrane was 4-fold higher, whereas the affinity of corticosterone was 20-fold lower. The data suggest that the substrate binding site of rOCT2 is like a pocket containing overlapping binding domains for ligands. These binding domains may undergo separate structural changes. From the extracellular surface, the affinity for uncharged corticosterone was increased by making membrane potential more negative. This implies potential-dependent structural changes in the extracellular binding pocket and existence of a voltage sensor. Interestingly, at 0 mV, an 18-fold higher affinity was determined for trans-inhibition of choline efflux by corticosterone compared with cis-inhibition of choline uptake. This suggests an additional high affinity-conformation of the empty outwardly oriented substrate binding pocket. A model is proposed that describes how substrates and inhibitors might interact with rOCT2. The data provide a theoretical basis to understand drug-drug interactions at polyspecific transporters for organic cations.Keywords
This publication has 32 references indexed in Scilit:
- Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cellsBritish Journal of Pharmacology, 2002
- Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transportersJournal of Pharmaceutical Sciences, 2001
- Mechanism of Electrogenic Cation Transport by the Cloned Organic Cation Transporter 2 from RatJournal of Biological Chemistry, 2000
- Selectivity of the Polyspecific Cation Transporter rOCT1 Is Changed by Mutation of Aspartate 475 to GlutamateMolecular Pharmacology, 1999
- Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporterNature Neuroscience, 1998
- A Nonparametric Test for the General Two-Sample ProblemPublished by JSTOR ,1998
- Human Neurons Express the Polyspecific Cation Transporter hOCT2, Which Translocates Monoamine Neurotransmitters, Amantadine, and MemantineMolecular Pharmacology, 1998
- Cloning and Characterization of Two Human Polyspecific Organic Cation TransportersDNA and Cell Biology, 1997
- Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1Journal of Biological Chemistry, 1996
- Drug excretion mediated by a new prototype of polyspecific transporterNature, 1994